Common actions of adenosine receptor agonists in modulating human trabecular meshwork cell transport.
about
Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.Mechanisms of ATP release by human trabecular meshwork cells, the enabling step in purinergic regulation of aqueous humor outflow.Cytoskeletal dependence of adenosine triphosphate release by human trabecular meshwork cellsCell-specific differential modulation of human trabecular meshwork cells by selective adenosine receptor agonists.Sustained elevation of extracellular ATP in aqueous humor from humans with primary chronic angle-closure glaucomaBarrier qualities of the mouse eye to topically applied drugs.Electron probe X-ray microanalysis of intact pathway for human aqueous humor outflowNucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species.Novel ocular antihypertensive compounds in clinical trials.Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathways.Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel.Ocular Purine Receptors as Drug Targets in the Eye.Endogenous production of extracellular adenosine by trabecular meshwork cells: potential role in outflow regulationComparative Study of the Effects of Trabecular Meshwork Outflow Drugs on the Permeability and Nitric Oxide Production in Trabecular Meshwork Cells.Differential P1-purinergic modulation of human Schlemm's canal inner-wall cells.Purinergic dysregulation causes hypertensive glaucoma-like optic neuropathy.
P2860
Q34530196-6A8C5B73-1228-4E29-A73F-8F294339CE92Q35050779-4AD4AE53-4E41-4F6A-89A0-71CA1DCF0178Q35562337-FC47229D-1459-41B0-ADFA-C2F035FF0A09Q35575133-FAD751AC-CDA6-40F1-B126-6565194FA2B0Q36030094-CD2C5C28-5C6A-472E-885F-CB3E91C3EED6Q36296623-D0165AA2-7220-44F8-A948-17AC2827C42CQ36977675-219D822F-1B42-42BC-9E63-BA89B3B382CFQ37461055-A48D52ED-F733-45CA-9D43-381F966D62C3Q37883078-96195878-B679-46C5-BC41-CAC18FFAE637Q38192030-B590279D-A172-4B25-8786-822BE5880C0AQ38584194-240EBAB9-53CE-4A40-8765-BE89647CC2DDQ39995538-931EE09A-6090-4F5A-BF97-D8C1FF20A8DAQ41651208-FD061E62-AB36-43B2-B5AB-2D5E9F73F579Q42085679-3806B3AF-51BF-4983-9991-14485A9E8112Q42262056-94798D9C-1D3D-43A6-82EE-5A1EBBD94D69Q45182499-9529931A-3F30-413A-93A3-875D31A8B348Q47863338-67F1B2AB-1264-406C-9603-0D4F81FFE799
P2860
Common actions of adenosine receptor agonists in modulating human trabecular meshwork cell transport.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Common actions of adenosine re ...... cular meshwork cell transport.
@en
Common actions of adenosine re ...... cular meshwork cell transport.
@nl
type
label
Common actions of adenosine re ...... cular meshwork cell transport.
@en
Common actions of adenosine re ...... cular meshwork cell transport.
@nl
prefLabel
Common actions of adenosine re ...... cular meshwork cell transport.
@en
Common actions of adenosine re ...... cular meshwork cell transport.
@nl
P2093
P1476
Common actions of adenosine re ...... cular meshwork cell transport.
@en
P2093
C H Mitchell
J C Fleischhauer
K Peterson-Yantorno
W D Stamer
P2860
P2888
P304
P356
10.1007/S00232-002-2013-5
P577
2003-05-01T00:00:00Z